Expertise

It's at the heart of everything we do

e.g. asthma, appendicitis, Wright, Peter Kroll

EvidenceCare offers healthcare providers complete access to content curated by some of the industry’s foremost experts. We continue to develop content to meet the needs of our customers.

Acute Coronary Syndrome (ACS)

William Brady

Acute Coronary Syndrome (ACS)

CME: Up to 8 Launch Protocol
The EvidenceCare Acute Coronary Syndrome (ACS) pathway is based off of the 2013 American College of Cardiology Foundation/American Heart Association (ACCF/AHA) STEMI guidelines, 2014 American College of Cardiology/American Heart Association (ACC/AHA) NSTEMI guidelines and includes the 2015 American Heart Association (AHA) Acute Coronary Syndromes update. All phases of ACS care are addressed, with focus on appropriate intervention strategies for NSTEMI and STEMI care, including care of patients after resuscitated cardiac arrest with suspected ACS. Included are the 2015 updates on STEMI care that reflect guideline changes based on the interval of time of symptom onset to intervention versus previous recommendations based on interval from first medical contact to intervention.
Read More

Advanced Cardiac Life Support (ACLS)

CME: Up to 2 Launch Protocol
The EvidenceCare Advanced Cardiac Life Support pathway is based off the 2015 American Heart Association (AHA) guidelines. This offers providers a structured approach to managing fatal arrhythmias and adult resuscitation. We summarize survival outcome data for in-hospital and out-of-hospital cardiac arrests.
Read More

Antibiotic Advisor

Frank LoVecchio

Antibiotic Advisor

Our Antibiotic Guide is a comprehensive resource for providers to access antimicrobial treatment regimens on nearly every infectious condition. Whether your patient has sepsis, Hospital-Acquired Pneumonia (HAP), or is a child with meningitis, we have you covered. Furthermore, we allow you to customize the treatment regimen based on variables (such as weight and drug allergies) that are specific to your patient.
Read More

Asthma

CME: Up to 4 Launch Protocol
The EvidenceCare Asthma pathway allows providers to utilize a structured approach to the management of pediatric and adult patients with Asthma. Topics that are covered include acute exacerbations and impending respiratory arrest. The Pediatric Asthma Score (PAS) and the Pediatric Respiratory Asthma Measurement (PRAM) are embedded as decision rules to help the provider risk stratify their patient. Guidelines recommendations are included from the Managing Asthma Exacerbations in the Emergency Department Summary of the National Asthma Education and Prevention Program Expert Panel (ATS 2009), British Guidelines on the Management of Asthma (2014), and multiple Cochrane Database Systematic Reviews.
Read More

C. diff (Pseudomembranous Colitis)

Christina Surawicz

C. diff (Pseudomembranous Colitis)

CME: Up to 2 Launch Protocol
Clostridium difficile infections (CDI) continue to be a great burden in the United States. In 2015, the CDC estimated there were close to 500,000 cases and 29,000 deaths within 30 days of diagnosis. The EvidenceCare C. diff pathway assists providers with appropriate prevention strategies, diagnosis, and treatment of CDI. A treatment algorithm is included based on your patient's severity of disease and number of recurrences. Optimal antibiotic selection for each subtype of CDI is included. There is a discussion on the evidence related to probiotic and fecal microbiota transplant (FMT) use to prevent recurrence of CDI. Evidence is included from the American College of Gastroenterology's (ACG) 2013 Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections as well as…
Read More

Chest Pain: Rule-out ACS

Amal Mattu

Chest Pain

CME: Up to 2 Launch Protocol
Chest pain is the second most common presentation in the emergency department with an estimated 5 million patients presenting annually. A large percentage of these patients are at a Low Risk for acute coronary syndrome and can be safely managed on an Outpatient basis. The EvidenceCare Low Risk Chest Pain pathway helps providers risk stratify their patient who present with chest pain that the provider does not have suspicion for Acute Coronary Syndrome (ACS). The strengths and limitations of 5 risk stratification tools (the HEART Score, HEARTS3, EDACS-ADP, and ADAPT-ADP) are reviewed. Each of these tools have been validated and have the ability to identify patients at Low Risk for Major Adverse Cardiac Event (MACE) within the next 30 days.…
Read More

Chronic Obstructive Pulmonary Disease (COPD)

CME: Up to 4 Launch Protocol
Chronic obstructive pulmonary disease, or COPD, is the 4th leading cause of death in the world. The EvidenceCare Chronic Obstructive Pulmonary Disease (COPD) protocol provides recommendations for the diagnostic work-up, optimal therapeutic management and disposition of an acute exacerbation of COPD based on severity and response to initial treatment. Recommendations are based on the latest research and guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD), the American Thoracic Society, the National Institute for Health and Care Excellence (NICE), and the Veteran’s Health Administration and Department of Defense (VA/DoD).
Read More

CLABSI (Central Line-Associated Bloodstream Infection)

Stephen Liang

CLABSI (Central line associated blood stream infections)

CME: Up to 2 Launch Protocol
Central line associated blood stream infections (CLABSI) are among the most frequent health care-associated infections today, with around 250,000 cases per year. CLABSIs cause substantial morbidity and mortality as well as increased costs to the health care system including prolonged hospital stays. A recent CDC report estimated the cost of each CLABSI event at $16,550. While CLABSIs are serious infections, they are often preventable when evidence-based guidelines are followed. The EvidenceCare CLABSI Prevention Protocol incorporates recommendations from the Infection Disease Society of America (IDSA), The Society for Healthcare Epidemiology of America (SHEA), and the Centers for Disease Control (CDC). These recommendations provide guidelines for the insertion of venous catheters, criteria for maintaining the catheter, and implementation of prompt discontinuation strategies.
Read More

Concussion

CME: Up to 3 Launch Protocol
Concussions present many challenges to providers including initial assessment of severity of injury, management of acute and prolonged concussive symptoms and evaluation of patients for readiness to return to activities. The EvidenceCare Concussion pathway provides recommendations for the immediate evaluation of mild traumatic brain injury and includes decision tools to assess the need for neuro-imaging. Recommendations are based on the latest research and guidelines from the American College of Emergency Physicians, Centers for Disease Control (CDC), Veterans Health Administration and Department of Defense (VA/DoD), Ontario Neurotrauma Foundation (ONF) and Consensus Statement from the 4th International Conference on Concussion in Sport.
Read More

Congestive Heart Failure (CHF)

Semhar Tewelde

Congestive Heart Failure (CHF)

CME: Up to 4 Launch Protocol
In the United States alone approximately 6 million suffer from heart failure (HF). The EvidenceCare Congestive Heart Failure pathway provides recommendations on the diagnostic work-up, optimal therapeutic management, and disposition of the acutely decompensated heart failure based on their severity of disease and volume status. This pathway also includes a risk stratification tool to assist providers in disposition decisions of patients who are mildly decompensated and may be candidates for treatment at home. The Congestive Heart Failure pathway is based on the 2013 ACCF/AHA Guideline for Management of Heart failure, 2012 European Society of Cardiology guidelines for Acute and Chronic Heart Failure, the 2010 Heart Failure Society of America Comprehensive Practice Guideline, and 2009 Society of Chest Pain Centers recommendations.
Read More

Neonatal Fever

Nathan Mick

Neonatal Fever

CME: Up to 2 Launch Protocol
The optimal diagnostic workup, empiric treatment, and appropriate disposition of the neonate (infants <90 days old) continues to be challenging for even the most experienced providers. The EvidenceCare Neonatal Fever pathway consolidates the most recent research in this area, and present a protocolized approach. We cover initial assessment and risk stratification of patients in Low Risk and High Risk groups (based on Boston, Rochester, and Philadelphia criteria), decisions about appropriate diagnostic workup, and optimal treatment for your patient.
Read More

Pediatric Advanced Life Support (PALS)

Ghazala Sharief

Pediatric Advanced Life Support

CME: Up to 2 Launch Protocol
The EvidenceCare Pediatric Advanced Life Support (PALS) pathway offers providers a structured approach to managing pediatric arrhythmias (bradycardia, tachycardia), pediatric resuscitation and post arrest care. We summarize survival outcome data for in-hospital and out-of-hospital cardiac arrests (OHCA). Recommendations are based off of the 2015 American Heart Association (AHA) guidelines.
Read More

Pediatric Appendicitis

Genevieve Santillanes

Pediatric Advanced Life Support

CME: Up to 4 Launch Protocol
Acute appendicitis is the most common surgical emergency in children and diagnosis is often challenging.A classic presentation is often lacking in children, who may present with vague and nonspecific signs and symptoms that mimic common conditions, such as gastroenteritis. Imaging strategies to aid in the diagnosis of appendicitis include Ultrasound, CT and MRI.Providers must consider if imaging is necessary, and if so, the strengths and limitations of each modality, including potential cancer risk from radiation exposure. The EvidenceCare Pediatric Appendicitis Pathway helps providers risk stratify patients to improve decision making.The Alvarado score, Pediatric Appendicitis Score, Harbor-UCLA Clinical Practice Guideline and Clinical Gestalt are all considered in risk stratification and management of suspected appendicitis.
Read More

Pneumonia

Frank LoVecchio

Antibiotic Advisor

CME: Up to 6 Launch Protocol
The EvidenceCare Pneumonia pathway allows the provider to determine the optimal treatment protocol for a patient with suspected Pneumonia. The protocol is broken down into management of patients with Community-Acquired (CAP), Hospital-Acquired (HAP), and Ventilator-Associated Pneumonia (VAP). In Community-Acquired Pneumonia patients the user is guided through risk stratification of the patient's clinical severity using the CURB-65, the Pneumonia Severity Index (PSI), or clinical gestalt. Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) consideration of whether the patient has any MRSA or Pseudomonas risk factors are taken into account to determine the optimal antibiotic regimen. Guidelines that are used in this pathway include the new 2016 IDSA HAP/VAP Guidelines, the NICE Guidelines for Pneumonia, and the IDSA/ATS Community-Acquired Pneumonia Guidelines.
Read More

Pulmonary Embolism (PE)

Jeffrey Kline

Pulmonary Embolism

CME: Up to 6 Launch Protocol
The diagnostic workup and proper treatment approach to patients with pulmonary embolism can be challenging. The EvidenceCare Pulmonary Embolism pathway includes a diagnostic algorithm using the Wells Score and PERC rule as well as workup of the pregnant patient. For patients positive for pulmonary embolism we help the provider risk stratify their patient including whether they have intermediate (submassive) or massive clot burden. From there we help the provider go through appropriate anticoagulation options, indications and contraindications to fibrinolytic therapy. Indications for catheter-directed fibrinolysis, ECMO, and rescue embolectomy are also discussed.
Read More

Seizures

CME: Up to 3 Launch Protocol
The EvidenceCare Seizure pathway provides treatment guidelines for management of seizures in the hospital setting and includes recommendations for new onset seizures, alcohol withdrawal seizures, and recurrent seizures in both adults and pediatric patients. Treatment recommendations address emergent initial treatment, urgent control therapy and treatment of refractory status epilepticus. Recommendations are based on the latest research and guidelines from the American College of Emergency Physicians and Neurocritical Care Society (NCS).
Read More

Sepsis

CME: Up to 2 Launch Protocol
Sepsis kills over 258,000 and is one of the mostly costly conditions in our healthcare system. The EvidenceCare Sepsis pathway provides treatment recommendations based on whether the patient has Sepsis, Severe Sepsis, or is in Septic Shock. We help providers determine when to utilize qSOFA, SOFA, and ultrasound-guided fluid resuscitation. These recommendations are based off of the 2015 updated Surviving Sepsis Campaign guidelines, the recently released Sepsis-3 guidelines, and data from the ProCESS, ARISE, and PROMISE trials.
Read More

Stroke (Acute Ischemic)

CME: Up to 6 Launch Protocol
Stroke is the leading cause of disability in the United States. The EvidenceCare Stroke pathway consolidates information essential for providers evaluating patients with concern for cerebrovascular accidents (Strokes). Outlined are the recommendations for fibrinolytic therapy in acute ischemic stroke, including data from the 2015 AHA Advisory statement regarding changes to the inclusion and exclusion criteria for administration of tPA. The pathway highlights new endovascular interventional approaches in Acute Ischemic Stroke. Information is based off of the 2013 American Heart Association (AHA) Acute Ischemic Stroke Guidelines and the 2015 updated AHA recommendations for Endovascular intervention, and the 2014 AHA Guidelines for the Prevention of Stroke in patients with Stroke and Transient Ischemic Attack.
Read More

Transient Ischemic Attack (TIA)

William Brady

Acute Coronary Syndrome (ACS)

CME: Up to 2 Launch Protocol
Stroke is the leading cause of disability in the United States. The EvidenceCare Stroke TIA protocol consolidates information essential for providers evaluating patients with concern for transient ischemic attacks (TIAs). Information is based off of the 2013 American Heart Association (AHA) Acute Ischemic Stroke Guidelines and the 2014 AHA Guidelines for the Prevention of Stroke in patients with Stroke and Transient Ischemic Attack.
Read More